| Literature DB >> 32210602 |
Ewa Markiewicz1, Olusola Clement Idowu1.
Abstract
Human skin demonstrates a striking variation in tone and color that is evident among multiple demographic populations. Such characteristics are determined predominantly by the expression of the genes controlling the quantity and quality of melanin, which can alter significantly due to the presence of small nucleotide polymorphism affecting various steps of the melanogenesis process and generally linked to the lighter skin phenotypes. Genetically determined, constitutive skin color is additionally complemented by the facultative melanogenesis and tanning responses; with high levels of melanin and melanogenic factors broadly recognized to have a protective effect against the UVR-induced molecular damage in darker skin. Long-term sun exposure, together with a genetic makeup responsible for the ability to tan or the activity of constitutive melanogenic factors, triggers defects in pigmentation across all ethnic skin types. However, sun exposure also has well documented beneficial effects that manifest at both skin homeostasis and the systemic level, such as synthesis of vitamin D, which is thought to be less efficient in the presence of high levels of melanin or potentially linked to the polymorphism in the genes responsible for skin darkening triggered by UVR. In this review, we discuss melanogenesis in a context of constitutive pigmentation, defined by gene polymorphism in ethnic skin types, and facultative pigmentation that is not only associated with the capacity to protect the skin against photo-damage but could also have an impact on vitamin D synthesis through gene polymorphism. Modulating the activities of melanogenic genes, with the focus on the markers specifically altered by polymorphism combined with differential requirements of sun exposure in ethnic skin types, could enhance the applications of already existing skin brightening factors and provide a novel approach toward improved skin tone and health in personalized skincare.Entities:
Keywords: ethnic skin types; hyper-pigmentation; melanogenesis; vitamin D
Year: 2020 PMID: 32210602 PMCID: PMC7069578 DOI: 10.2147/CCID.S245043
Source DB: PubMed Journal: Clin Cosmet Investig Dermatol ISSN: 1178-7015
Genes and Biomarkers of Melanogenesis Relevant to Personalized Skincare
| Key Steps of Melanogenesis | |||
|---|---|---|---|
| 1 | UV-induced DNA synthesis of POMC (proopiomelanocortin). Processing of POMC to α-MSH (α-melanocyte-stimulating-hormone) and ACTH (adrenocorticotropic hormone) | ||
| 2 | Binding of α-MSH or ACTH to MC1R (melanocortin 1 receptor) and its activation | ||
| 3 | Activation of ADCY (adenylate cyclase) and increased formation of cAMP | ||
| 4 | Activation of PKA (protein kinase A) and phosphorylation of CREB (cAMP responsive-element binding) family of transcription factors | ||
| 5 | CREB-mediated expression of MITF (microphthalmia transcription factor), master regulator of melanocyte development and survival | ||
| 6 | MITF-induced expression of TYR (tyrosinase), TYRP1 (tyrosinase-related protein 1) and TYRP2/DCT (tyrosinase related protein-2/dopachrome tautomerase) through interactions with M- and E-boxes present in the promoter regions. TYR and TYRP1 are delivered to stage II melanosomes | ||
| 7 | Enzymatic oxidation of tyrosine by TYR to DOPA (l-3,4-dihydroxyphenylalanine) and DOPAquinone | ||
| 8a | Spontaneous conversion of DOPAquinone, via DOPAchrome, to DHI (5,6-dihydroxyindole) and DHICA (5,6-dihydroxyindole-2-carboxylic acid) accelerated by TYRP2/DCT | 8b | Reaction of DOPAquinone with cysteine to produce 5SCD (5-S-cysteinyldopa) and 2SCD (2-S-cysteinyldopa) |
| 9a | Oxidization of DHI and DHICA by TYR and TYRP1 to eumelanin polymer | 9b | Oxidization to intermediates which polymerize to pheomelanin |
| 10 | ASIP (agouti signaling protein); an antagonist of MC1R. Binding to MC1R leads to decreased TYR activity resulting in pheomelanin production | ||
| 11 | IRF4 (interferon regulatory factor 4); involved in transcription of TYR, TYRP1 and TYRP2. MITF directly or indirectly regulates IRF4 expression | ||
| 12 | ATRN (attractin) Group XI C-type lectin, trans-membrane protein, functions as accessory receptor for Agouti protein | ||
| 13 | Wnt/β-catenin; activation of nuclear β-catenin by Wnt leads to increased expression of MITF and melanogenesis | ||
| 14 | GSS (glutathione synthetase); involved in GSH (glutathione) biosynthesis. Role in the switch between eumelanogenesis and pheomelanogenesis through interactions with TYR and DOPAquinone | ||
| 15 | GGT7 (gamma-glutamyltransferase 7); membrane-associated protein involved in metabolism of glutathione and the trans-peptidation of amino acids | ||
| 16 | RALY (RALY heterogeneous nuclear ribonucleoprotein); RNA binding protein | ||
| 17 | EIF2S2 (eukaryotic translation initiation factor 2); functions in the early steps of protein synthesis | ||
| 18 | EIF6 (eukaryotic translation initiation factor 6); role in protein synthesis | ||
| 19 | DRD2 (dopamine receptor D2); signaling shows increase with increasing UV exposure | ||
| 20 | KITLG (hyper-pigmentation c-KIT receptor). Development and migration of melanocyte lineages, activates MAPK (mitogen activated protein kinase) leading to up-regulated expression of MITF, which activates keratinocytes to produce factors promoting melanosome phagocytosis | ||
| 21 | EDA (ectodysplasin A). Trans-membrane protein of the TNF (tumor necrosis factor) family, cytokine involved in the epithelial-mesenchymal signaling | ||
| 22 | ITCH (itchy homolog); E3 ubiquitin-protein ligase, induces proteasomal degradation | ||
| 23 | HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2); regulates ubiquitin-dependent retention of repair proteins on damaged chromosomes | ||
| 24 | BNC2 (basonuclin 2); zinc finger protein, cell survival after oxidative stress | ||
| 25 | SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 2). Member of the large ATP-dependent chromatin remodeling complex SNF/SWI required for transcriptional activation of repressed genes | ||
| 26 | DDB1 (DNA damage- binding protein 1); involved in DNA nucleotide excision repair, functions as a core component of the E3 ubiquitin ligase complexes | ||
| 27 | EGFR (epidermal growth factor receptor); induces cell proliferation and differentiation | ||
| 28 | FGF7 (fibroblasts growth factor); enhances melanin synthesis and melanocyte proliferation, stimulates melanosome transfer after UVB irradiation | ||
| 29 | SCF (stem cell factor); fibroblast factor, enhances melanin synthesis and melanocyte proliferation | ||
| 30 | UQCC (ubiquinol-cytochrome c reductase complex); trans-membrane protein involved in FGF regulated growth control | ||
| 31 | VLDLR (very-low-density-lipoprotein receptor); trans-membrane receptor involved in endocytosis | ||
| 32 | PROCR (protein C receptor); cell survival and proliferation | ||
| 33 | ADAM17 (ADAM metallopeptidase domain 17); involved in cell adhesion and migration | ||
| 34 | ADAMTS 20 (ADAM metallopeptidase with thrombospondin type 1 motif 20); involved in cell adhesion and migration | ||
| 35 | Pme17 (Premelanosome protein); early melanosome development and maturation, fibrils optimize condensation of melanin | ||
| 36 | OCA2 (oculocutaneous albinism type 2); chloride anion channel protein, effector of melanosomal pH, glutathione metabolism, processing and trafficking of tyrosinase to melanosomes | ||
| 37 | SLC45A2/MATP (solute carrier family 45 member 2). Membrane transporter; ion transport; increases pH and TYR activity | ||
| 38 | SLC24A4 (solute carrier family 24 member 4). Membrane transporter; impact on TYR activity | ||
| 39 | SLC24A5/NCKX5 (solute carrier family 24 member 5). Membrane transporter; a putative NA+/Ca2+ ion exchanger pump, impact on TYR activity | ||
| 40 | MFSD12 (major facilitator superfamily domain containing 12); trans-membrane solute transporter in endosomes and lysosomes in melanocytes. Depletion of MFSD12 increases eumelanin content | ||
| 41 | TMEM38 (trans-membrane protein 38); lysosomal protein, monovalent cation channel, functions in maintenance of intracellular calcium | ||
| 42 | SNX13 (sorting nexin 13); involved in the intracellular trafficking and lysosomal degradation | ||
| 43 | EDEM2 (ER degradation enhancing alpha-mannosidase like protein 2), protein folding and trafficking | ||
| 44 | DTNBP1 (dystrobrevin binding protein 1); melanosome biogenesis | ||
| 45 | MAP1LC3A (microtubule associated protein 1 light chain 3 alpha); mediates the physical interactions between microtubules and elements of the cytoskeleton | ||
| 46 | MYO5A (myosin VA); transport of melanosomes in melanocytes, target of MITF | ||
| 47 | LYST (lysosomal trafficking regulator,CHS1); vesicular transport protein, regulated by MITF | ||
| 48 | EXOC2 (exocyst complex component 2); exocytosis, melanosome trafficking, actin remodeling | ||
Single Nucleotide Polymorphism (SNP) and Changes in Gene Expression Affecting Melanogenic Traits in Different Skin Types
| Gene | Skin Type | Gene Alterations and Phenotypes |
|---|---|---|
| Melanin synthesis | ||
| MC1R | Caucasian | Allelic diversity; sun sensitivity and freckles |
| Oriental | Allelic diversity; lighter skin reflectance and freckles | |
| MITF | Caucasian | Allelic diversity, polymorphism correlates with the levels of serum 25[OH]D, impact on vitamin D status and deficiency |
| IRF4 | Caucasian | Allelic diversity, reduced skin tanning response, freckling and sun sensitivity |
| GSS | Caucasian | Allelic diversity |
| GGT7 | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| RALY | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| EIF2S2 | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| EIF6 | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| ASIP | Caucasian | Polymorphism associated with sensitivity to sun and freckling |
| Oriental | Allelic diversity | |
| ATRN | Oriental | Allelic diversity |
| DRD2 | Oriental | Allelic diversity |
| TYR | Caucasian | Involved in normal variation of pigmentation. Polymorphism correlated with the levels of serum 25[OH]D, impact on vitamin D status and deficiency |
| Indian | Accounts for the differences between darkest and lightest skin reflectance | |
| TYRP1 | Caucasian | Polymorphism correlated with the levels of serum 25[OH]D, impact on vitamin D status and deficiency |
| Oriental | Allelic diversity | |
| Indian | Allelic diversity. Frequently associated with red-bronze skin | |
| African | Allelic diversity. Frequently associated with red-bronze skin | |
| TYRP2/DCT | Caucasian | Allelic diversity |
| Oriental | Allelic diversity | |
| Indian | Allelic diversity | |
| African | Allelic diversity | |
| Melanocyte biogenesis and survival | ||
| ITCH | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| UQCC | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| PROCR | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| KITLG | Caucasian | Allelic diversity |
| Oriental | Allelic diversity | |
| EDA | Caucasian | Allelic diversity |
| EDA | Oriental | Allelic diversity |
| BNC2 | Caucasian | Allelic diversity |
| Oriental | Allelic diversity | |
| EGFR | Caucasian | Allelic diversity |
| Oriental | Allelic diversity | |
| ADAM17 | Oriental | Allelic diversity |
| ADAMTS20 | Oriental | Allelic diversity |
| DDB1 | Caucasian | Allelic diversity |
| Oriental | Allelic diversity | |
| Indian | Allelic diversity | |
| African | Allelic diversity | |
| HERC2 | Caucasian | Allelic diversity |
| Indian | Allelic diversity | |
| African | Allelic diversity | |
| SMARCA2 | African | Allelic diversity |
| VLDLR | African | Allelic diversity |
| Melanosome biogenesis and trafficking | ||
| EDEM2 | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| DTNBP1 | Caucasian | Allelic diversity. Polymorphism correlated with the levels of serum 25[OH]D |
| MAP1LC3 | Caucasian | Lower expression levels in the lightly-pigmented melanocytes |
| EXOC2 | Caucasian | Polymorphism correlated with the levels of serum 25[OH]D, impact on vitamin D status and deficiency |
| MYO5A | Caucasian | Allelic diversity. Polymorphism correlated with the levels of serum 25[OH]D |
| LYST | Oriental | Allelic diversity |
| SLC24A4 | Caucasian | Allelic diversity |
| Indian | Allelic diversity | |
| SLC45A2/MATP | Caucasian | Polymorphism associated with olive skin and immature melanosomes |
| Oriental | Allelic diversity | |
| Indian | Allelic diversity | |
| African | Allelic diversity | |
| OCA2 | Caucasian | Allelic diversity |
| Oriental | Allelic diversity; major gene contributing to skin lightening | |
| Indian | Allelic diversity | |
| African | Allelic diversity | |
| SLC24A5 | Caucasian | Allelic diversity. Mutations disrupt melanosomal maturation and melanin biosynthesis |
| Oriental | Allelic diversity | |
| Indian | Allelic diversity at very high frequencies | |
| African | Allelic diversity at very high frequencies | |
| MFSD12 | African | Allelic diversity |
| SNX13 | African | Allelic diversity |
| TMEM38 | African | Allelic diversity |
Figure 1Interactive networks of the major melanogenic genes and gene polymorphism or altered gene expression affecting pigmentation in four ethnic skin types. The biomarkers have been assembled based on the literature;25–90,158–162 the genes affected in each skin type are marked yellow.
Current Applications and Active Ingredients for Improvement of Skin Tone
| Molecules with broad chemical nature and mechanisms of action. The most popular include hydroquinone (HQ) and its derivatives monobenzyl ether of hydroquinone (MBEH), monomethyl ether of hydroquinone (MMEH), benzaldehyde analogs; chalcone analogs; phenolic amines and derivatives of 4-phenylimidazole-2-thione, mequinol, N-acetyl glucosamine, benzimidazole-2-thiol, phenylthiol, phenylthiourea (PTU), p-aminobenzoic acid (PABA), quinazoline, biphenyl derivatives, indole derivatives and thiosemicarbazone. |
| Usually contain a combination of active natural ingredients that work in synergy. Some skin-lightening compounds in such extracts include aloesin, anisic acid, arbutin, trans-cinnamaldehyde, p-coumaric acid, cumic acid, epicatechin gallate, ellagic acid, glabridin, hesperidin, kaempferol, 2-oxyresveratrol, resveratrol, azelaic acid, aurone, hydroxystilbenes, hydroxycinnamic acid derivatives, chalcones and trihydroxyflavones, caffeic acid and ginsenoside Rb1. |
| De-pigmenting derivatives of resorcinol (1,3-benzendiol) include 4-cycloalkylresorcinol, 4-cycloalkylmethylresorcinols, 4-haloresorcinol, 4-(1,3) dithian-2-ylresorcinols and 4-n-butyl resorcinol (rucinol). |
| Reduce the synthesis of melanin by quenching ROS generated through exposure to UVR and oxidization of TYR and DOPA. |
| The capacities to increase turnover rate of melanin (vitamin A), inhibit the transfer of melanosomes from melanocytes to keratinocytes (vitamin B3), interfere with the glycosylation of TYR (vitamin B5), de-activation of UVR-induced ROS and inhibition of TYR (vitamin C) and protection against UVR-induced inflammation (vitamin E). |
| Ingredients interfering with melanosome transfer include niacinamide and lectins. |
| Molecules with inhibitory effect on melanocyte activity or survival include fomiferin and its derivative fomiferin-3,4-dimethyl ether, fraxidin methyl ether, hernlarin, imperatorin, kuhlmannin, obliquin, osajin and its derivative osajin-4-methyl ether, pachyrrhizin, prenyletin, robustic acid, sphondin, warangalone and xanthyletin. |
| Reduce pigmentation through interaction with the protease-activated receptor 2 (PAR-2) in keratinocytes affecting melanin and melanosome uptake by keratinocytes. Custom designed oligopeptides between 6 and 12 amino acids, dipeptides or cyclic peptides have the capacity to translocate to melanosomes and inhibit TYR. |
| The molecules that indirectly inhibit TYR expression through down-regulation of cAMP include glyceollin, methyl and ethyl linoenates, platycodin, bisabolangelone, chrysin, paeonol. |
| Applications as superficial chemical peels, target stratum corneum and accelerate desquamation of the outer epidermal layers, increasing melanin turnover. Increase the enzymatic activities leading to epidermolysis and promoting the synthesis of elastin fibers. The most commonly used are glycolic, lactic, citric, malic, pyruvic and salicylic acids and their derivatives. |
| Wnt/β-catenin signaling pathway enhances MITF gene expression and melanogenesis; ingredients inhibiting the pathway through enhanced degradation of β-catenin include cardamonin, fingolimod, pyridinyl imidazoles and andrographolide. |
| Based on double-stranded, ~21 base pairs RNA with the sequence complementary to the target mRNA. Mediate gene silencing and inhibition of TYR by binding the mRNA and degrading it at the site of application. |
| AP-1 and its interacting partner kinesin family member 13A (KIF13A) are required for the transfer of melanogenic enzymes to melanosomes and their maturation. Inhibition of KIF13A or AP-1 decreases the expression of melanogenic enzymes and synthesis of melanin. |
| Dexamethasone, fluocinolone acetonide and tranexamic acid have applications in treatment of hyper-pigmentation defects. |
| Based on laser treatment, cryotherapy and dermoabrasion. |
| The potential capacities to protect the skin from photodamage by increasing the melanin content. The ingredients include pyrazoles, indole alkaloids, cannabinoid derivatives and 2-bromopolymitate derivatives. |
Figure 2Proposed functional cluster targets for enhancement of skin tone and prevention of pigmentation problems in four skin types whilst retaining the capacity for vitamin D synthesis and defense against molecular damage caused by UVR.